The diabetic milieu modulates the advanced glycation end product- receptor complex in the mesangium by inducing or upregulating galectin-3 expression

Diabetes

Volumn 49, Issue 7, 2000, Pages 1249-1257

  Pugliese, Giuseppe ^a,d   Pricci, Flavia ^a,b   Leto, Gaetano ^a   Amadio, Lorena ^a   Iacobini, Carla ^a   Romeo, Giulio ^a   Lenti, Luisa ^a   Sale, Patrizio ^a   Gradini, Roberto ^a   Liu, Fu Tong ^c   Di Mario, Umberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d Diabet Endocrinol Metab Found   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE OVEREXPRESSION; GLYCATION; MESANGIUM CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 17644434954     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.7.1249     Document Type: Article

References (44)

1. Vlassara H, Bucala R, Striker LJ: Pathogenic effects of advanced glycosylation: biochemical, biological, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
2. Vlassara H: Protein glycation in the kidney: role in diabetes and aging. Kidney Int 49:1785-1804, 1996
3. Pugliese G, Pricci F, Romeo G, Menè P, Pugliese F, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U: Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation endproducts (AGEs) via a receptor-mediated mechanism. Diabetes 46:1881-1887, 1997
4. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ: Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. Proc Natl Acad Sci U S A 89:2873-2877, 1992
5. Li YM, Mitsuhashi T, Wojciechowicz D, Shimizu N, Li J, Stitt A, He C, Banerjee D, Vlassara H: Molecular identity and cellular distribution of advanced glycation end product receptors: relationship of p60 to OST-48 and p90 to 80 K-H membrane proteins. Proc Natl Acad Sci U S A 93:11047-11052, 1996
6. Vlassara H, Li YM, Imani Y, Wojciechowicz D, Yang A, Liu F-T, Cerami A: Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1:634-040, 1995
7. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267:14998-15004, 1992
8. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi U, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijt JK, vanBerkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T: A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386:292-296, 1997
9. Barondes SH, Cooper DNW, Gitt MA, Leffler H: Galectins: structure and function of a large family of animal lectins. J Biol Chem 269:20807-20810, 1995
10. Liu F-T: S-type mammalian lectins in allergic inflammation. Immunol Today 14:486-490, 1993
11. Inohara H, Raz A: Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 55:3267-3271, 1995
12. Ochieng J, Leite-Browning ML, Warfield P: Regulation of cellular adhesion to extracellular matrix proteins by Galectin-3. Biochem Biophys Res Commun 246:788-791, 1998
13. Raz A, Lotan R: Endogenous galactoside-binding lectins: a new class of functional tumor cell surface molecules related to metastasis. Cancer Metastasis Rev 6:433-452, 1987
14. Kuwabara I, Liu F-T: Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156:3939-3944, 1996
15. Hsu DK, Zuberi RI, Liu F-T: Biochemical and biophysical characterization of human recombinant IgE-binding protein: an S-type lectin. J Biol Chem 267:14167-14174, 1992
16. Dagher SF, Wang JL, Patterson RJ: Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A 92:1213-1217, 1995
17. Yang RY, Hsu DK, Liu F-T: Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 93:0737-6742, 1996
18. Inohara H, Akaliani S, Raz A: Galectin-3 stimulates cell proliferation. Exp Cell Res 245:294-302, 1998
19. Kadrofske MM, Openo KP, Wang JL: The human LGALS3 (Galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys 349:7-20, 1998
20. Pugliese G, Pricci F, Pesce CM, Romeo G, Lenti E, Vetri M, Caltabiano V, Purrello F, Di Mario U: Early, but not advanced, experimental diabetic glomerulopathy is reversed by pancreatic islet transplants: correlation with glomerular extracellular matrix mRNA levels. Diabetes 46:1198-1206, 1997
21. Pugliese G, Pricci F, Pugliese F, Menè P, Lenti L, Andreani D, Galli G, Casini A, Bianchi S, Rotella CM, Di Mario U: Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes 43:478-490, 1994
22. Hamann KK, Cowles EA, Wang JL, Anderson RL: Expression of carbohydrate binding protein 35 in human fibroblasts: variations in the levels of mRNA, protein, and isoelectric species as a function of replicative competence. Exp Cell Res 196:82-91, 1991
23. Moutsatsos IK, Wade M, Schindler M, Wang JL: Endogenous lectins from cultured cells: nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc Natl Acad Sci U S A 84:6452-6456, 1987
24. Bucala R, Tracey KJ, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87:432-438, 1991
25. Sensi M, Pricci F, De Rossi MG, Bruno MR, Morano S, Capuozzo E, Di Mario U: Formation and ways of detecting advanced glycation endproducts in isolated human glomerular basement membrane and human serum albumin non-enzymatically glycated in vitro. J Diabetes Complications 3:88-91, 1989
26. Makita Z, Vlassara H, Crami A, Bucala R: Immunochemical detection of advanced glycosylation endproducts in vivo. J Biol Chem 267:5133-5138, 1992
27. Yamagishi Si, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H: Advanced glycation end products-driven angiogenesis in vitro: induction of the growth and tube formation of human microvasoular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272:8723-8730, 1997
28. Yang CW, Vlassara H, Peten EP, He CJ, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci U S A 91:9436-9440, 1994
29. F-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest 99:457-468, 1997
30. Sugimoto H, Shikata K, Wada J, Horiuchi S, Makino H: Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-α and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42:878-886, 1999
31. Sensi M, Pricci F, Pugliese G, De Rossi MG, Cristina A, Morano S, Pozzessere G, Valle E, Andreani D, Di Mario U: Enhanced tissue levels of advanced glycation endproducts in experimental diabetes: possible role in late diabetic complications. Diabetes Res Clin Pract 28:9-17, 1995
32. Skolnik E, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174:931-939, 1991
33. Sato S, Hughes RC: Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem 269:4424-4430, 1994
34. Frigeri LG, Zuberi RI, Liu F-T: εBP, a β-galactoside-binding animal lectin, recognizes IgE receptor (Fc-εRI) and activates mast cells. Biochemistry 32:7644-7649, 1993
35. Liu F-T, Hsu DK, Zuberi RI, Shenhav A, Hill PN, Kuwabara I, Chen SS: Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domain. Biochemistry 35:6073-6079, 1996
36. Claudio RT, De Luca A, Howard CM, Baldi A, Firpo EJ, Koff A, Paggi MG, Giordano A: Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 56:2003-2008, 1996
37. Frigeri LG, Robertson MW, Liu F-T: Expression of biologically active recombinant rat IgE-binding protein in Escherichia coli. J Biol Chem 265: 20763-20769, 1990
38. Winyard PJD, Bao Q, Hughes RC, Woolf AS: Epithelial galectin-3 during human nephrogenesis and childhood cystic disease. J Am Soc Nephrol 8:1647-1657, 1997
39. Sasaki S, Bao Q, Hughes RC: Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies. J Pathol 187:481-489, 1999
40. Youssef S, Nguyen DT, Soulis T, Panagiotopoulos S, Jerums G, Cooper ME: Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding. Kidney Int 55:907-916, 1999
41. Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, Cooper ME: Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 40:619-628, 1997
42. Stitt AW, He C, Vlassara H: Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. Biochem Biophys Res Commun 256:549-556, 1999
43. He C-J, Stitt A, Striker LJ, Hattori M, Vlassara H: Low expression of AGE-receptor-1 in NOD mouse mesangial cells: possible link to diabetic nephropathy (Abstract). J Am Soc Nephrol 7:1871, 1996
44. Yang R-Y, Hill PN, Hsu DK, Liu F-T: Role of the carboxyl-terminal lectin domain in self-association of galectin-3. Biochemistry 37:4086-4092, 1998